Phase 1 TAK-915 Single-Dose Positron Emission Tomography (PET) Occupancy Study

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

This phase 1 study will be conducted to examine the degree and duration of brain PDE2A enzyme occupancy /target engagement as a function of TAK-915 plasma concentration in order to guide dosing and schedule for future clinical studies in schizophrenia with TAK-915.

Key facts

Study ID
NCT02584569
Run by
Takeda
People needed
12
Starts
2015-11-01
Expected to finish
2016-04-01
Last updated by the study team
2016-07-21

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.